Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons

Journal of Neuroscience Research

Volumn 80, Issue 5, 2005, Pages 677-682

  Rzeski, Wojciech ^a,b   Kocki, Tomasz ^c   Dybel, Anna ^d   Wejksza, Katarzyna ^a   Zdzisińska, Barbara ^a   Kandefer Szerszeń, Martyna ^a   Turski, Waldemar A ^b,c   Okuno, Etsuo ^e   Albrecht, Jan ^d  

^a MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^e WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Astrocytes; Immunocytochemistry; Kynurenic acid; Kynurenic acid aminotransferase; Neurons

Indexed keywords

2 AMINOBICYCLO[2.2.1]HEPTANE 2 CARBOXYLIC ACID; 2 OXOISOCAPROIC ACID; 4 AMINOPYRIDINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINOOXYACETIC ACID; GLUTAMIC ACID; GLUTAMINE; IONOTROPIC RECEPTOR AGONIST; KYNURENIC ACID; KYNURENINE; KYNURENINE AMINOTRANSFERASE; KYNURENINE AMINOTRANSFERASE I; KYNURENINE AMINOTRANSFERASE II; LEUCINE; N METHYL DEXTRO ASPARTIC ACID; NEUROMUSCULAR DEPOLARIZING AGENT; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN CELL; BRAIN CORTEX; CONTROLLED STUDY; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSAMINATION;

ANIMALS; ANTIBODIES; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; GLUTAMIC ACID; GLUTAMINE; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KYNURENIC ACID; LEUCINE; NEURONS; RATS; RATS, WISTAR; TRANSAMINASES;

EID: 21244441558     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20505     Document Type: Article

References (32)

1. Alkondon M, Pereira EF, Yu P, Arruda EZ, Almeida LE, Guidetti P, Fawcett WP, Sapko MT, Randall WR, Schwarcz R, Tagle D, Albuquerque EX. 2004. Targeted deletion of the kynurenine aminotransferase II gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J Neurosci 24:4635-4648.
2. Baran H, Jellinger K, Deecke L. 1999. Kynurenine metabolism in Alzheimer's disease. J Neural Transm 106:165-181.
3. Battaglia G, Rassoulpour A, Wu HQ, Hodgkins PS, Kiss C, Nicoletti F, Schwarcz R. 2000. Some metabotropic glutamate receptor ligands reduce kynurenate synthesis in rats by intracellular inhibition of kynurenine aminotransferase II. J Neurochem 75:2051-2060.
4. Brookes N. 1993. Interaction between the glutamine cycle and the uptake of large neutral amino acids in astrocytes. J Neurochem 60:1923-1928.
5. Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteri M, Moroni F. 2001. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci 13:2141-2147.
6. Curatolo L, Caccia C, Speciale C, Raimondi L, Cini M, Marconi M, Molinari A, Schwarcz R. 1996. Modulation of extracellular kynurenic acid content by excitatory amino acids in primary cultures of rat astrocytes. Adv Exp Med Biol 398:273-276.
7. Du F, Schmidt W, Okuno E, Kido R, Köhler C, Schwarcz R. 1992. Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus. J Comp Neurol 321:477-487.
8. Erhardt S, Oberg H, Engberg G. 2001. Pharmacologically elevated levels of endogenous kynurenic acid prevent nicotine-induced activation of nigral dopamine neurons. Naunyn Schmiedebergs Arch Pharmacol 363:21-27.
9. Gramsbergen JB, Hodgkins PS, Rassoulpour A, Turski WA, Guidetti P, Schwarcz R. 1997. Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem 69:290-298.
10. Hertz L, Juurlink BHJ, Hertz E, Fosmark H, Schousboe AS. 1989. Preparation of primary cultures of mouse (rat) astrocytes. In: Shahar A, DeVellis J, Vernadakis A, Haber B, editors. A dissection and tissue culture manual for the nervous system. New York: Alan R. Liss, Inc. p 105-108.
11. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX. 2001. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21: 7463-7473.
12. Hodgkins PS, Wu HQ, Zielke HR, Schwarcz R. 1999. 2-Oxoacids regulate kynurenic acid production in the rat brain: studies in vitro and in vivo. J Neurochem 72:643-651.
13. Kapoor R, Okuno E, Kido R, Kapoor V. 1997. Immuno-localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord. Neuroreport 8:3619-3623.
14. Kiss C, Ceresoli-Borroni G, Guidetti P, Zielke CL, Zielke HR, Schwarcz R. 2003. Kynurenate production by cultured human astrocytes. J Neural Transm 110:1-14.
15. Knyihar-Csillik E, Okuno E, Vecsei L. 1999. Effects of in vivo sodium azide administration on the immunohistochemical localization of kynurenine aminotransferase in the rat brain. Neuroscience 94:269-277.
16. Knyihar-Csillik E, Csillik B, Pakaski M, Krisztin-Peva B, Dobo E, Okuno E, Vecsei L. 2004. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) treatment. Neuroscience 126:899-914.
17. Kocki T, Dolińska M, Dybel A, Urbańska EM, Turski WA, Albrecht J. 2002. Regulation of kynurenic acid synthesis in C6 glioma cells. J Neurosci Res 68:622-626.
18. Litchfield JT, Wilcoxon F. 1949. A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-113.
19. Malherbe P, Alberati-Giani D, Kohler C, Cesura AM. 1995. Identification of a mitochondrial form of kynurenine aminotransferase/glutamine transaminase K from rat brain. FEBS Lett 367:141-144.
20. Obrenovitch TP, Urenjak J. 2000. In vivo assessment of kynurenate neuroprotective potency and quinolinate excitotoxicity. Amino Acids 19:299-309.
21. Rejdak R, Źarnowski T, Turski WA, Okuno E, Kocki T, Zagòrski Z, Kohler K, Guenther E, Zrenner E. 2001. Presence of kynurenic acid and kynurenine aminotransferases in the inner retina. Neuroreport 12:3675-3678.
22. Rzeski W, Pruskil S, Macke A, Felderhoff-Mueser U, Reiher AK, Hoerster F, Jansma C, Jarosz B, Stefovska V, Bittigau P, Ikonomidou C. 2004. Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol 56:351-360.
23. Saran T, Hilgier W, Kocki T, Urbańska EM, Turski WA, Albrecht J. 1998. Acute ammonia treatment in vitro and in vivo inhibits the synthesis of a neuroprotectant kynurenic acid in rat cerebral cortical slices. Brain Res 787:348-350.
24. Saran T, Hilgier W, Urbańska EM, Turski WA, Albrecht J. 2004. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy. J Neurosci Res 75:436-440.
25. Scharfman HE, Goodman JH, Schwarcz R. 2000. Electrophysiological effects of exogenous and endogenous kynurenic acid in the rat brain: studies in vivo and in vitro. Amino Acids 19:283-297.
26. Schwarcz R, Pellicciari R. 2002. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 303:1-10.
27. +-independent transporter of neutral amino acids in astrocytes. J Neurosci 9:2066-2072.
28. Turski WA, Gramsbergen JB, Traitler H, Schwarcz R. 1989. Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J Neurochem 52:1629-1636.
29. Urbańska EM, Kocki T, Saran T, Kleinrok Z, Turski WA. 1997. Impairment of brain kynurenic acid production by glutamate metabotropic receptor agonists. Neuroreport 8:3501-3504.
30. Wu HQ, Baran H, Ungerstedt U, Schwarcz R. 1992. Kynurenic acid in the quinolinate-lesioned rat hippocampus: studies in vitro and in vivo. Eur J Neurosci 4:1264-1270.
31. Wu HQ, Monno A, Schwarcz R, Vezzani A. 1995. Electrical kindling is associated with a lasting increase in the extracellular levels of kynurenic acid in the rat hippocampus. Neurosci Lett 198:91-94.
32. Yudkoff M. 1997. Brain metabolism of branched-chain amino acids. Glia 21:92-98.